Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Jan 2026.
- Largest single sale: $6.9M (100,532 shares) of Arrowhead Pharmaceuticals, Inc. on Dec 15, 2025. Filing
- Last sale before this period: Apr 11, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Executive Officer, Director | Jan 24, 2008 | Jan 5, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 2, 2026, Arrowhead Pharmaceuticals, Inc.: sold 13,187 shares for $872K, under a disclosed plan. 1 filing: 1
- Dec 29, 2025, Arrowhead Pharmaceuticals, Inc.: sold 51,726 shares for $3.6M, under a disclosed plan; 51,726 shares acquired by exercising options. 1 filing: 1
- Dec 22, 2025, Arrowhead Pharmaceuticals, Inc.: sold 12,586 shares for $861K, under a disclosed plan. 1 filing: 1
- Dec 19, 2025, Arrowhead Pharmaceuticals, Inc.: sold 13,445 shares for $910K, under a disclosed plan. 1 filing: 1
- Dec 17, 2025, Arrowhead Pharmaceuticals, Inc.: sold 85,000 shares for $5.4M, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.